Target intelligence / Profile preview

Mammalian transporter

Molecular classification
Transporter, Membrane protein, Solute carrier, ATP-binding cassette transporter
01

Overview

Mammalian transporters are a vast class of membrane proteins that facilitate the movement of ions, nutrients, and xenobiotics across biological membranes (UniProt, 2024). They are broadly divided into the Solute Carrier (SLC) superfamily, which includes over 400 members, and the ATP-Binding Cassette (ABC) superfamily (Hediger et al., 2013). These proteins are essential for maintaining cellular homeostasis, regulating pH, and managing the uptake of vital substances like glucose and amino acids (NIH, 2023). In the context of pharmacology, transporters are critical components of the ADME (Absorption, Distribution, Metabolism, and Excretion) profile of drugs, often determining the bioavailability and tissue distribution of therapeutic agents (Giacomini et al., 2010). Many transporters are direct therapeutic targets, such as the serotonin transporter (SERT) for antidepressants or the sodium-glucose cotransporter 2 (SGLT2) for diabetes (PubMed, 2023). However, they are also frequent sites of drug-drug interactions, where one drug inhibits the transport of another, leading to potential toxicity (FDA, 2020). Genetic polymorphisms in transporter genes can significantly impact individual drug responses and disease susceptibility (StatPearls, 2024).

Other names
Membrane transporterSolute carrier (SLC)ATP-binding cassette transporter (ABC transporter)Ion transporterDrug transporter
02

Mechanism of action

Inhibition of substrate translocation, competitive inhibition at the binding site, non-competitive or allosteric modulation of transport activity, and induction or repression of transporter expression (Giacomini et al., 2010; PubMed, 2023).

03

Biological functions

Nutrient transportIon homeostasisXenobiotic effluxNeurotransmitter reuptakeWaste excretionSignal termination
04

Disease associations

CancerDiabetes mellitusGoutCystic fibrosisDepressionHypertensionCholestasis
05

Safety considerations

Drug-drug interactions (DDIs)Altered pharmacokinetics leading to systemic toxicityInterference with essential nutrient uptakeMultidrug resistance (MDR)
06

Interacting drugs

Metformin

6 more in the full profile.

07

Biomarkers

CreatinineBilirubinSLCO1B1*5 genetic variantABCG2 c.421C>A genetic variant

Beyond the preview

Go deeper on Mammalian transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mammalian transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call